DAE HWA Pharmaceutical Co., Ltd. (KOSDAQ:067080)
South Korea
· Delayed Price · Currency is KRW 15,010
-10 (-0.07%)
At close: Apr 28, 2026
DAE HWA Pharmaceutical Ratios and Metrics
Market cap in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Apr '26 Apr 27, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Market Capitalization | 262,925 | 305,315 | 191,632 | 164,306 | 164,657 | 163,255 | Upgrade
|
| Market Cap Growth | -6.07% | 59.32% | 16.63% | -0.21% | 0.86% | -39.51% | Upgrade
|
| Enterprise Value | 358,668 | 402,655 | 288,813 | 265,142 | 243,200 | 219,445 | Upgrade
|
| Last Close Price | 15010.00 | 17430.00 | 10838.56 | 9161.15 | 9028.01 | 8795.54 | Upgrade
|
| PE Ratio | 159.68 | 184.65 | 360.61 | - | 147.59 | 73.63 | Upgrade
|
| PS Ratio | 1.84 | 2.13 | 1.28 | 1.16 | 1.25 | 1.39 | Upgrade
|
| PB Ratio | 3.32 | 3.86 | 2.51 | 2.12 | 2.02 | 1.96 | Upgrade
|
| P/TBV Ratio | 6.01 | 6.98 | 4.49 | 3.67 | 3.27 | 2.96 | Upgrade
|
| P/FCF Ratio | 101.46 | 117.82 | 218.93 | - | - | 232.62 | Upgrade
|
| P/OCF Ratio | 48.44 | 56.25 | 36.50 | - | 20.10 | 15.72 | Upgrade
|
| EV/Sales Ratio | 2.51 | 2.82 | 1.93 | 1.88 | 1.84 | 1.87 | Upgrade
|
| EV/EBITDA Ratio | 38.04 | 42.70 | 22.02 | 33.85 | 23.41 | 27.08 | Upgrade
|
| EV/EBIT Ratio | 113.42 | 127.33 | 43.03 | 135.12 | 41.60 | 66.82 | Upgrade
|
| EV/FCF Ratio | 138.41 | 155.38 | 329.96 | - | - | 312.68 | Upgrade
|
| Debt / Equity Ratio | 1.22 | 1.22 | 1.30 | 1.43 | 1.10 | 0.84 | Upgrade
|
| Debt / EBITDA Ratio | 10.26 | 10.26 | 7.57 | 14.11 | 8.67 | 8.66 | Upgrade
|
| Debt / FCF Ratio | 37.35 | 37.35 | 113.42 | - | - | 99.96 | Upgrade
|
| Net Debt / Equity Ratio | 1.15 | 1.15 | 1.20 | 1.25 | 1.00 | 0.62 | Upgrade
|
| Net Debt / EBITDA Ratio | 9.62 | 9.62 | 6.97 | 12.39 | 7.90 | 6.38 | Upgrade
|
| Net Debt / FCF Ratio | 34.99 | 34.99 | 104.43 | -10.64 | -4.21 | 73.71 | Upgrade
|
| Asset Turnover | 0.69 | 0.69 | 0.70 | 0.68 | 0.70 | 0.67 | Upgrade
|
| Inventory Turnover | 2.89 | 2.89 | 3.35 | 3.86 | 4.10 | 3.85 | Upgrade
|
| Quick Ratio | 0.22 | 0.22 | 0.25 | 0.29 | 0.33 | 0.49 | Upgrade
|
| Current Ratio | 0.51 | 0.51 | 0.52 | 0.51 | 0.62 | 0.75 | Upgrade
|
| Return on Equity (ROE) | 3.00% | 3.00% | 1.08% | -0.65% | 1.48% | 2.31% | Upgrade
|
| Return on Assets (ROA) | 0.95% | 0.95% | 1.97% | 0.59% | 1.94% | 1.17% | Upgrade
|
| Return on Invested Capital (ROIC) | 0.92% | 0.91% | 2.15% | 1.16% | 1.97% | 1.04% | Upgrade
|
| Return on Capital Employed (ROCE) | 3.50% | 3.50% | 7.60% | 2.20% | 5.00% | 3.20% | Upgrade
|
| Earnings Yield | 0.63% | 0.54% | 0.28% | -0.70% | 0.68% | 1.36% | Upgrade
|
| FCF Yield | 0.99% | 0.85% | 0.46% | -5.55% | -11.84% | 0.43% | Upgrade
|
| Dividend Yield | 1.00% | - | - | 1.64% | 1.66% | - | Upgrade
|
| Payout Ratio | 159.57% | 158.90% | 494.43% | - | 235.51% | 118.28% | Upgrade
|
| Buyback Yield / Dilution | 0.70% | 0.70% | -1.13% | - | -0.33% | -0.87% | Upgrade
|
| Total Shareholder Return | 1.70% | 0.70% | -1.13% | 1.64% | 1.34% | -0.87% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.